• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Device Problems Leak/Splash (1354); Device Dislodged or Dislocated (2923)
Patient Problems Hemorrhage/Bleeding (1888); Test Result (2695)
Event Date 11/18/2015
Event Type  Injury  
Manufacturer Narrative
Literature citation: chaudhuri a, dey r, multi-component parallel endografts at complex tevar may be prone to modular dislocation causing novel endoleaks: a tale of two cases, ejves short reports (2015), http://dx.Doi.Org/10.1016/j.Ejvssr.2015.10.004.Concomitant medical products: alpha thoracic, cook aortic device, 8mm x 10cm gore® viabahn® endoprostheses with propaten bioactive surface no lot number information was supplied; therefore, no review of the manufacturing paperwork could be performed.The device remained implanted; consequently, a direct product analysis was not possible.
 
Event Description
In the medical literature, "multi-component parallel endografts at complex tevar may be prone to modular dislocation causing novel endoleaks: a tale of two cases" was reviewed.Two cases of complex thoracic endovascular aneurysm repair (tevar) with endoleakage due to modular dislocation of multi-component left subclavian parallel endografts in periscope configuration were reported.In this case, a (b)(6) female presented with a 75mm thoracic aortic aneurysm.She underwent a hybrid periscope-tevar procedure using two overlapped thoracic endoprostheses (alpha thoracic, cook aortic) and two 8mm x 10cm gore® viabahn® endoprostheses with propaten bioactive surface.The gore® viabahn® endoprostheses were synchronously deployed as a left subclavian artery periscope via an open brachial approach with an intentioned 2-cm overlap.After 48 hours, the patient was discharged with no complications and a palpable left radial pulse.It was stated that a computed tomography angiogram in the second week post procedure revealed modular dislocation between the two gore® viabahn® endoprostheses with endoleakage into the thoracic aortic aneurysm sac.A repeat computed tomography angiogram at 8 weeks post procedure revealed sac enlargement to 85mm with both components of the left subclavian artery periscope still patent.The patient underwent an urgent re-line of the left subclavian artery periscope.The two components of the periscope were bridged with an 8mm x 10cm gore® viabahn® endoprosthesis with propaten bioactive surface.The completion angiogram revealed no endoleaks and the patient was discharged home with a good left radial pulse, and no neurological complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86001
Manufacturer Contact
sandra whicker
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key5299944
MDR Text Key33594551
Report Number2017233-2015-00885
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,litera
Reporter Occupation Physician
Type of Report Initial
Report Date 11/19/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/15/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age67 YR
-
-